DOSE.F Stock Overview
Through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Doseology Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.15 |
| 52 Week High | CA$0.72 |
| 52 Week Low | CA$0.014 |
| Beta | 0 |
| 1 Month Change | 9.16% |
| 3 Month Change | -17.95% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -78.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| DOSE.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -36.0% | -2.6% | -0.2% |
| 1Y | n/a | -23.3% | 25.6% |
Return vs Industry: Insufficient data to determine how DOSE.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how DOSE.F performed against the US Market.
Price Volatility
| DOSE.F volatility | |
|---|---|
| DOSE.F Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: DOSE.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine DOSE.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Shawn Balaghi | doseology.com |
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of nutraceutical products in Canada. It provides medicinal mushroom products, including tinctures, powders, and adaptogenic herbal supplements to enhance health with a focus on mental health. The company sells its products online through doseology.com, as well as through various retail chains.
Doseology Sciences Inc. Fundamentals Summary
| DOSE.F fundamental statistics | |
|---|---|
| Market cap | US$1.19m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs DOSE.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOSE.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DOSE.F perform over the long term?
See historical performance and comparison